Search Results - "Sanden, S"

Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996–2011 by van der Sanden, S. M. G., Koopmans, M. P. G., van der Avoort, H. G. A. M.

“…Laboratories of the Dutch Working Group on Clinical Virology have routinely performed enterovirus diagnostics in the Netherlands since the early 1960s, with…”
Get full text

Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes by Olmos, D, Lorente, D, Alameda, D, Cattrini, C, Romero-Laorden, N, Lozano, R, Lopez-Casas, P P, Jambrina, A, Capone, C, Vanden Broecke, A M, Trevisan, M, Van Sanden, S, Jürgens, A, Herrera-Imbroda, B, Castro, E

“…Although germline BRCA mutations have been associated with adverse outcomes in prostate cancer (PC), understanding of the association between somatic/germline…”
Get more information

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy by Backx, M., Lewszuk, A., White, J. R., Cole, J., Sreedharan, A., van Sanden, S., Diels, J., Lawson, A., Neal, K. R., Wiselka, M. J., Ito, T., Irving, W. L.

“…Summary Chronic hepatitis C virus (HCV) infection places a considerable economic burden on health services. Cost‐effectiveness analyses of antiviral treatment…”
Get full text

Influence of equilibrium charge reservoir formation on photo generated charge transport in TiO2/organic devices by SANDEN, S, SANDBERG, O. J, XU, Q, SMATT, J.-H, JUSKA, G, LINDEN, M, ÖSTERBACKA, R

Get full text

An Indirect Comparison of Iwqol-Lite total Score Change In Subjects treated with Canagliflozin, Exenatide qw, Sitagliptin, or Pioglitazone In dual Therapy With Background Metformin by Traina, S, Slee, A, Van Sanden, S, Diels, J

Get full text

Bayesian Network Meta-Analysis (Nma) to Assess Relative Efficacy of Canagliflozin (Cana) Versus Glucagon-Like Peptide-1 (Glp-1) Agonists in Dual and Triple Therapy In Patients with type 2 Diabetes Mellitus (T2dm) by Van Sanden, S, Diels, J, Guillon, P, Nielsen, A.T

Get full text

Bortezomib Re-treatment in Patients with Multiple Myeloma (MM). A Real World Medical Practice Experience from a Swedish National Registry by Thilakarathne, P, Diels, J, van Sanden, S, Liwing, J, Chirita, O, Van Agthoven, M, Nahi, H

Get full text

Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden by Thilakarathne, P, Diels, J, van Sanden, S, Liwing, J, Van Agthoven, M, Chirita, O, Nahi, H

Get full text

Network Meta-Analysis With Baseline Risk Adjustment To Assess The Relative Efficacy Of Ustekinumab In Adult Patients With Active Psoriatic Arthritis by Van, Sanden S, Diels, J, Van, Laer J, Hemels, M

Get full text

Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv) by Taieb, V, Pacou, M, Van Sanden, S, Sbarigia, U, Mehnert, A, Duchesne, I

Get full text

Simulation Model of Ibrutinib in Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL) by Peng, S, Sorensen, S, Pan, F, Dorman, E, Sun, S, Van Sanden, S, Sengupta, N, Gaudig, M

Get full text

Non-Inferiority of Once-Daily Cobicistat-Boosted Darunavir Versus Ritonavir-Boosted Darunavir in Hiv-1-infected Adult Patients: An Adjusted Comparative Analysis of Pooled Phase 3 Data by Van Sanden, S, Thilakarathne, P, Opsomer, M, Mrus, J, Vanveggel, S, Lathouwers, E, Adriaenssen, I

Get full text

Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple Myeloma by Thilakarathne, P, Palumbo, A, Diels, J, Delforge, M, van Sanden, S, Mateos, M.V, Chirita, O, Dimopoulos, M.A, van de Velde, H, San Miguel, J.F

Get full text

PND10 Faster Cognitive Decline is Associated With Decreasing Survival in Patients With Alzheimer'S Disease by van Sanden, S, Diels, J, Gaudig, M, Spencer, M, Thompson, G, Arrighi, H.M

Get full text

Bayesian Network Meta-Analysis to Assess the Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (MET+SU) by Pacou, M, Taieb, V, Abrams, K.R, Diels, J, van Sanden, S, Garg, M, Schroeder, M, Kaur, V, Nielsen, A.T.N, Nuhoho, S, Neslusan, C, Hemels, M

Get full text

Bayesian Network Meta-Analysis to Assess Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin by Pacou, M, Taieb, V, Abrams, K.R, Diels, J, van Sanden, S, Garg, M, Schroeder, M, Kaur, V, Nielsen, A.T.N, Nuhoho, S, Neslusan, C, Hemels, M

Get full text

PCN37 - MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF APALUTAMIDE AND ENZALUTAMIDE IN THE TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER by Chowdhury, S., Oudard, S., Hadaschik, B.A., Uemura, H., Joniau, S., Pilon, D., Ladouceur, M., Behl, A., Liu, J., Dearden, L., Sermon, J., Van Sanden, S., Diels, J.

Get full text

Podocyte-specific expression of cre recombinase in transgenic mice by Moeller, Marcus J., Sanden, Silja K., Soofi, Abdulsalam, Wiggins, Roger C., Holzman, Lawrence B.

“…We report a transgenic mouse line that expresses Cre recombinase exclusively in podocytes. Twenty‐ four transgenic founders were generated in which Cre…”
Get full text

PB2014: TECLISTAMAB VS SELINEXOR‐DEXAMETHASONE IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING‐ADJUSTED INDIRECT COMPARISON by Rosinol, L., Usmani, S. Z., Bahlis, N., Krishnan, A. Y., Nooka, A. K., Oriol, A., Delforge, M., Garfall, A. L., Donk, N. W., Rodríguez Otero, P., Martin, T. G., Diels, J., Van Sanden, S., Pei, L., Ammann, E., Kobos, R., Slavcev, M., Smit, J., Londhe, A., Moreau, P.

Get full text

P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE‐CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING‐ADJUSTED INDIRECT TREATMENT COMPARISON by Delforge, M., Usmani, S. Z., Donk, N. W., Garfall, A. L., Moreau, P., Oriol, A., Nooka, A. K., Rosinol, L., Bahlis, N., Rodriguez‐Otero, P., Martin, T., Diels, J., Van Sanden, S., Pei, L., Ammann, E., Kobos, R., Slavcev, M., Smit, J., Londhe, A., Krishnan, A.

Get full text